AzTrials
AzTrials

DeafnessHEAR2SHARENCT07321691

Evaluation of the Effectiveness of a Rehabilitation Program for Hearing and Communication Disorders in Elderly People in Nursing Homes.

A study testing use of hearing rehabilitation device in people with Deafness, run by University Hospital, Toulouse at 1 site in France.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

In France, 64% of residents in nursing homes have moderate to severe hearing loss and only 12% are treated with hearing aids. Yet the extra-auditory consequences of presbycusis are numerous: general fatigue, isolation, anxiety and depression. Read more about this study

Who is it for?
Ages 60 years and older
Conditions the study is for
Deafness
What is being tested?
use of hearing rehabilitation device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
1 siteFrance
Study dates
Sep 2026to Feb 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 60 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • residents in nursing homes with hearing impairment (HHIE-S (Hearing Handicap Inventory for the Elderly Screening and pure tone audiometry)
  • with an MMS (Mini Mental State) score> 15
  • with a GIR Group ≥ à 3 affiliated to a social security scheme
  • French speaking

Who cannot join

  • wearing any type of hearing aid at the time of inclusion
  • having followed a similar training program
  • Subjects under juridical protections or tutelage measure
  • unable to answer questions and participate in group activities
  • with associated life-threatening pathologies and/or a life expectancy in EHPAD of less than 6 months

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Professor Mathieu MARX contact

05-61-77-77-04

marx.m@chu-toulouse.fr

Soumia TAOUI contact

taoui.s@chu-toulouse.Fr

France1 site
  • University Hospital Toulouse

    Toulouse, 31059

    Mathieu MARX, MD, 05-61-77-77-04, marx.m@chu-toulouse.fr

    Soumia TAOUI, taoui.s@chu-toulouse.fr

Other trials in France

About this study

Official title: Evaluation of the Effectiveness of a Rehabilitation Program for Hearing and Communication Disorders in Elderly People in Nursing Homes: a Single Case Experimental Design (N of 1 Trials Study)

In France, 64% of residents in nursing homes have moderate to severe hearing loss and only 12% are treated with hearing aids. Yet the extra-auditory consequences of presbycusis are numerous: general fatigue, isolation, anxiety and depression. France counted 620 000 nursing home beds in 2020 and this number increases each year by an average of 2% (DREES (Department of Research, Studies, Evaluation and Statistics), France, 2019). Only few studies have focused on hearing disorders in this population, given the importance of their communication difficulties (Solheim J et al., 2016, Kimball A et al., 2017 ). The population in nursing homes is for 80% over 80 years old (DREES (Department of Research, Studies, Evaluation and Statistics) survey, France, 2014). This same survey looked at the proportion of people with functional hearing limitations and their severity depending on where they live. The highest rates were found among people living in institutions (regardless of the degree of functional hearing limitations), with 42% of people living in nursing homes and senior residences who have hearing functional limitations against 15.9 % of those living at home The present study is interested in the management of hearing and communication disorders in nursing homes residents by setting up a program for the rehabilitation of these disorders, based on the use of a simple hearing device by the nursing home staff.

Read the detailed description

The main objective of this study is to assess the effectiveness of a rehabilitation program for hearing and communication disorders intended to improve the communication of residents in nursing homes.

This program includes for the resident:

  • the alternative use of two hearing rehabilitation devices aimed to improve audibility
  • An inaugural training led by a trained professional to promote oral communication The effectiveness of the two devices will be compared.

This program includes for the staff members:

  • A one-day training comprising three components (general concepts concerning deafness and its rehabilitation, training in the use of the device to improve audibility, training in facilitating the communication workshop).
Conditions
Deafness
Being tested
use of hearing rehabilitation device
Keywords
deafness, rehabilitation, nursing homes, elderly subject
Medical subject headings
Deafness

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • use of hearing rehabilitation deviceOther

    the use hearing rehabilitation devices aimed to improve audibility

Study groups in NCT07321691
Study groupRoleWhat they receive
transmitter with receiverExperimentalhearing rehabilitations : a transmitter with several receivers
Receives: Other: use of hearing rehabilitation device
listening assistant.Active comparatorone type of hearing rehabilitations
Receives: Other: use of hearing rehabilitation device
No hearing deviceNo interventionno hearing device

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. effectiveness of the Hear2Share program

    The primary outcome will be the effectiveness of the Hear2Share program evaluated by the Percentage of words correctly identified at 60 dB HL measured every weeks

    Measured: every weeks from enrollment until end of participation at 15 weeks

Secondary outcomes (1)
  1. wearing time of the device

    wearing time of the device in hours and every weeks

    Measured: From enrollment to the end of participation at 15 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Jan 2026
  2. Study startSep 2026 (estimated)
  3. Primary completionFeb 2028 (estimated)
  4. Study completionFeb 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Sequential
Model description
Single Case Experimental Design (SCED) consists in repeated measures in a small sample size. Each subject acts as his own control.
Masking
None (open label)
Enrolment
40 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07321691
Sponsor's protocol ID
RC31/23/0390
Other IDs
2025-A01543-46
Acronym
HEAR2SHARE
Status last verified
May 2026
First submitted
22 Dec 2025
Last updated
19 May 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing use of hearing rehabilitation device in people with Deafness, run by University Hospital, Toulouse at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 19 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Professor Mathieu MARX (05-61-77-77-04, marx.m@chu-toulouse.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

effectiveness of the Hear2Share program (time frame: every weeks from enrollment until end of participation at 15 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 May 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in